Overview
Immerse yourself in research which offers the opportunity to make a significant impact on the development of medicines and their clinical use with our Pharmacology research degree. You’ll examine molecular, cellular, whole organ and patient samples, explore computational approaches to the study of drug-induced pharmacological mechanisms, and identify treatment strategies that ultimately improve patient outcomes.
Introduction
The Institute of Systems, Molecular and Integrative Biology (ISMIB) was established to integrate cutting-edge and clinical research across the Faculty of Health and Life Sciences. Programmes of work across ISMIB are varied and are led by world experts in their fields.
The Department of Pharmacology and Therapeutics is a Queen’s award-winning department, internationally recognised for excellence in innovative research, with research partners across the world. We provide excellent opportunities for basic and clinical research in antimicrobial therapies, immunopharmacology, cancer pharmacology, cardiovascular pharmacology, personalised medicines, long-acting therapies, complex medicines and nanotherapeutics. Drug safety and date science are key themes across our research activity.
We offer state-of-the-art research facilities and have funding from sources including the Medical Research Council (MRC), Biotechnology and Biological Sciences Research Council (BBSRC), Wellcome Trust, National Institute for Health and Care Research (NIHR), Wolfson Foundation and the EU.
Research topics
We welcome research proposals around the following themes:
- The biological effects of therapeutics in humans
- Non-human or non-clinical studies conducted with the intent to advance therapies to the clinic or develop principles for the application of therapeutics to human disease
- Investigations in humans which define the biology of disease and provide the scientific foundation for the development of new or improved therapies for human disease
- The biology-chemistry “bridge”
- Drug safety science
- Personalised medicine
- Immunopharmacology
- The pharmacology of infectious disease
- Complex medicines and long-acting therapeutics
- Biomaterials
- Neuropharmacology.
Research culture
Cutting-edge and clinical research takes place across a variety of research groups and networks. These include:
- Centre of Excellence for Long-acting Therapeutics (CELT), sharing our world-leading expertise in pharmacology and materials chemistry to disseminate research findings in long-acting medicine and change the global landscape of drug administration
- Centre for Drug Safety Science (CDSS), informing the future design of medicines, providing an environment for cross-disciplinary collaboration and training the next generation of drug safety scientists.
- AMR-X Liverpool, a collaborative action research network, dedicated to optimising antibiotic treatment
Intracellular Drug Delivery Centre (IDDC), a £10 million Innovate UK funded National Centre of Excellence, where we are a key partner. The centre is driving research in complex medicines for application in areas such as infectious disease and gene therapy, assessing biological interactions related to safety, biodistribution and efficacy.